Ms. Schinkel joined Poseida in October 2019 and serves as vice president, clinical operations. She has over 24 years of clinical drug development experience in clinical operations including half of that time focused on contributing to pharmaceutical and biotech efforts in the San Diego area. Most recently, she was an executive director at Retrophin leading clinical operations including strategic planning, clinical supply oversight and clinical outsourcing/vendor management. Prior to that, Angie provided leadership at Halozyme Therapeutics across multiple development programs. In addition, she has held senior management positions of increasing responsibility at Amylin Pharmaceuticals and Spectrum Pharmaceuticals. Ms. Schinkel earned a Master’s Degree in Organizational Psychology from Alliant University as well as a Bachelor of Arts in Psychology from the University of California San Diego.